Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9801 |
High Similarity |
NPD4967 |
Phase 2 |
0.9801 |
High Similarity |
NPD4966 |
Approved |
0.9801 |
High Similarity |
NPD4965 |
Approved |
0.9603 |
High Similarity |
NPD37 |
Approved |
0.9545 |
High Similarity |
NPD6234 |
Discontinued |
0.925 |
High Similarity |
NPD7228 |
Approved |
0.8938 |
High Similarity |
NPD7199 |
Phase 2 |
0.8909 |
High Similarity |
NPD7240 |
Approved |
0.8712 |
High Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.8314 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.8284 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8268 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.8118 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8113 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.8087 |
Intermediate Similarity |
NPD7680 |
Approved |
0.8057 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7988 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7963 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7953 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7929 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7862 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7829 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7816 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7805 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7784 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7784 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7759 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7714 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7679 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7661 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7633 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7622 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7613 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7593 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7593 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7586 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7584 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.758 |
Intermediate Similarity |
NPD1613 |
Approved |
0.758 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7574 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7574 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7572 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7571 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7571 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7564 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.755 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7544 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7542 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7542 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7528 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7527 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7515 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7515 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7485 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7485 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD2801 |
Approved |
0.747 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7468 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7456 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.743 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7421 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7414 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7407 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7407 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7407 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7401 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7396 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7385 |
Intermediate Similarity |
NPD7827 |
Phase 1 |
0.7378 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7378 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7372 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.736 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7351 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7346 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7346 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7346 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7342 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7342 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7342 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7341 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7337 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7337 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7333 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7326 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7325 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.731 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7301 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7301 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7301 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7296 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7296 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7251 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.725 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.725 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7244 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7241 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7228 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7225 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7205 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD919 |
Approved |
0.7193 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD5005 |
Approved |
0.7188 |
Intermediate Similarity |
NPD5006 |
Approved |
0.7184 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7179 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7178 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7178 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.717 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7166 |
Intermediate Similarity |
NPD7296 |
Approved |
0.7161 |
Intermediate Similarity |
NPD1608 |
Approved |
0.716 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7125 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7125 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7108 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7104 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7101 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7099 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7099 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7097 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7093 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7081 |
Intermediate Similarity |
NPD6663 |
Approved |
0.7071 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7071 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7068 |
Intermediate Similarity |
NPD4420 |
Approved |
0.7063 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7059 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7055 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7049 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7049 |
Intermediate Similarity |
NPD7038 |
Approved |
0.7044 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7041 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7039 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7019 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7013 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7006 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7006 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD1933 |
Approved |
0.6988 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6988 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6987 |
Remote Similarity |
NPD1091 |
Approved |
0.6987 |
Remote Similarity |
NPD1281 |
Approved |
0.6983 |
Remote Similarity |
NPD5711 |
Approved |
0.6983 |
Remote Similarity |
NPD5710 |
Approved |
0.6982 |
Remote Similarity |
NPD5058 |
Phase 3 |
0.6981 |
Remote Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6968 |
Remote Similarity |
NPD17 |
Approved |
0.6966 |
Remote Similarity |
NPD6746 |
Phase 2 |
0.6964 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6964 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6949 |
Remote Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.6946 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6944 |
Remote Similarity |
NPD5242 |
Approved |
0.6937 |
Remote Similarity |
NPD3018 |
Phase 2 |
0.6937 |
Remote Similarity |
NPD5736 |
Approved |
0.6932 |
Remote Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.6932 |
Remote Similarity |
NPD5353 |
Approved |
0.6928 |
Remote Similarity |
NPD4476 |
Approved |
0.6928 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.6928 |
Remote Similarity |
NPD4477 |
Approved |
0.6928 |
Remote Similarity |
NPD2796 |
Approved |
0.6928 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6927 |
Remote Similarity |
NPD2973 |
Approved |
0.6927 |
Remote Similarity |
NPD2975 |
Approved |
0.6927 |
Remote Similarity |
NPD1247 |
Approved |
0.6927 |
Remote Similarity |
NPD2974 |
Approved |
0.6923 |
Remote Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.6919 |
Remote Similarity |
NPD920 |
Approved |
0.6915 |
Remote Similarity |
NPD6841 |
Approved |
0.6915 |
Remote Similarity |
NPD6842 |
Approved |
0.6915 |
Remote Similarity |
NPD6843 |
Phase 3 |
0.6914 |
Remote Similarity |
NPD7985 |
Registered |
0.6907 |
Remote Similarity |
NPD6781 |
Approved |
0.6907 |
Remote Similarity |
NPD6778 |
Approved |
0.6907 |
Remote Similarity |
NPD6782 |
Approved |
0.6907
|
Remote Similarity |
NPD6779 |
Approved |